Lilly promotes CFO Rice to executive VP

Kaitlyn Dmyterko | | Cardiovascular Business | Structural Heart Disease
Derica Rice has been appointed the executive vice president of Eli Lilly with expanded responsibilities in the company’s global services sector.

Effective Jan. 1, 2010, Rice will abandon his position of senior vice president to take on the added roles. According to the Indianapolis-based company, Rice will continue to serve as the company’s chief financial officer (CFO).

According to Lilly, Rice joined the company in 1999 as an international treasury associate, where he was later promoted to vice president and controller in 2003. Rice has been acting CFO of the pharmaceutical company since his election in 2006.

Kaitlyn Dmyterko

Related Content

Treating younger patients with TAVR increases risk of death
Self-expanding vs. balloon-expandable TAVR valves: How they compare after 5 years
New data put a spotlight on troubling TAVR trends
How robotic-assisted mitral valve repair compares to conventional surgery
Tricuspid TEER shows clinical efficacy for first time in newest TRILUMINATE data
Cardiology societies push Medicare to pay for tricuspid TEER

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Design by Adaptive Theme
Trimed Popup
Trimed Popup